Institutional or government requirements
Defined medicine requirements connected to an institutional procurement need, subject to the procurement rules and import requirements that apply locally.
International pharmaceutical supply
KOIT coordinates manufacturers, buyers, importers, regulatory stakeholders and documentation for defined pharmaceutical requirements that may fall outside a routine commercial import structure.
SPI explained
Special Purpose Import is a practical description for importing a pharmaceutical product for a defined institutional, regulatory, programmatic or other non-standard requirement. Unlike routine commercial import, the proposed supply is connected to a specific purpose, responsible party and intended use.
It is not a single universal statutory scheme. The available pathway, terminology and evidence required can differ by country and may also change according to the product, quantity, intended use and authority involved.
KOIT acts as an international pharmaceutical business-development and coordination partner. We help the responsible parties evaluate a workable supply structure; we do not grant permits, registrations or regulatory approvals, and we do not guarantee authorization.
Potential use cases
These examples can provide a starting point for assessment. None is automatically eligible: the proposed route must be confirmed for the individual requirement.
Defined medicine requirements connected to an institutional procurement need, subject to the procurement rules and import requirements that apply locally.
Products required for a specific healthcare initiative, public-health program or other approved use with a defined responsible organization.
Product quantities needed for an evaluation, regulatory process or other formally recognized purpose where the destination authority permits an appropriate route.
Pharmaceutical supply connected to a specific approved project, program or time-bound requirement rather than routine commercial distribution.
Cases where a standard commercial import structure may not fit, assessed individually against the product, purpose, destination and applicable rules.
KOIT's role
We connect the product requirement with appropriate supply capabilities and coordinate the information needed by the responsible commercial and regulatory stakeholders.
Assess the product requirement and identify suitable manufacturing capabilities, specifications, pack formats and potential supply sources.
Align the requirement with the qualified buyer, importer or responsible local organization and clarify each party's role in the proposed import.
Coordinate available product, quality and manufacturer documents needed for review by the responsible buyer, local partner or authority.
Work with the relevant stakeholders to identify documentary and procedural requirements without representing that KOIT grants an authorization or approval.
Connect manufacturers, commercial parties and logistics providers around agreed quantities, timelines, responsibilities and documentary flows.
Support consistency across product, commercial, shipping and import documents as the requirement moves from review toward supply.
Local requirements
Import requirements are country- and purpose-specific. Depending on the case, the responsible local party may need an import authorization, permit, product information, manufacturer documentation, quality certificates or other evidence requested by the applicable authority.
KOIT coordinates the exchange and alignment of available information among the manufacturer, importer, buyer, regulatory professionals and other stakeholders. The responsible local entity remains accountable for confirming and obtaining the approvals required in its market.
Product registration and regulatory supportSupply capability
KOIT assesses the requirement against a curated international manufacturer network, considering product capability, quality standards, documentation, pack configuration, volume and timing. India is an important sourcing origin within this network, but each requirement is matched to the most suitable available source rather than being built around one country.
Choosing an import structure
The appropriate structure depends on why the product is required and which route the destination market permits.
Generally supports routine market supply through the established local registration, import, distribution and commercial framework for the product. The responsible importer follows the normal requirements that apply to ongoing commercial distribution.
Begins with a specific institutional, regulatory, programmatic or other defined requirement. Any available route must be assessed for that exact product, purpose and market; it does not bypass registration or local import law.
International markets
KOIT develops pharmaceutical opportunities across Latin America, Southeast Asia, Africa and other regulated and emerging markets. The structure is always led by the destination market's rules and the role of the qualified local buyer, importer or institutional counterpart.
Where manufacturers, buyers and commercial partners sit in different jurisdictions, KOIT can also evaluate whether a coordinated cross-border trade structure is relevant to the requirement.
Merchant Trade TransactionsQualified counterparties
A viable requirement depends on responsible organizations with clear commercial, regulatory and supply-chain roles.
Process
Every engagement is reviewed individually before a supply route is proposed.
Related capability
Special Purpose Import can connect sourcing, regulatory and cross-border coordination around one defined requirement.
FAQ
Special Purpose Import describes a coordinated pharmaceutical import for a defined institutional, regulatory, programmatic or other non-standard purpose where the routine commercial import structure may not be suitable. It is not one universal statutory scheme: the available route and its name depend on the destination market, product, intended use and applicable authority.
It may be relevant to a specific institutional requirement, healthcare or public-health program, regulatory evaluation, approved project or another defined need. Each case must be assessed locally, and inclusion in one of these categories does not automatically make a product or transaction eligible.
KOIT can identify and coordinate with suitable manufacturers based on the product, quantity, quality, documentation and destination-market requirements. Final manufacturer selection and supply remain subject to technical, commercial and regulatory review.
No. Special Purpose Import must not be treated as a way to bypass product registration or local import law. Whether a particular route is available, and how it relates to registration requirements, must be determined by the responsible local stakeholders and applicable authority.
The appropriately qualified importer, buyer or other responsible local entity must obtain any permits, authorizations or approvals required in the destination market. KOIT coordinates information and documentation but does not issue permits, grant approvals or act as the local authority.
It may be relevant where an institution or approved program has a defined pharmaceutical requirement, but eligibility is not automatic. The product, purpose, procurement framework, responsible importer and destination-market rules must all be reviewed for the specific case.
KOIT develops pharmaceutical opportunities across Latin America, Southeast Asia, Africa and other regulated and emerging markets. Support for a specific requirement depends on having suitable manufacturers, qualified local counterparties and a viable route under the destination market's requirements.
SPI enquiry
Tell us about the product, intended purpose and target market. KOIT will review the requirement and respond directly.
Submission does not guarantee regulatory approval or replace any local import requirement.
Have a defined requirement?
Share the product, quantity, intended purpose and destination market. KOIT will assess the sourcing, documentation and coordination requirements with the relevant parties.